Stock Market News 15 hours agoShould You Buy Before the Ex-Dividend Date or Wait? Whether you're a newcomer to the world of dividend stocks or a veteran, the question of whether to buy before the ex-dividend date will always be one to ponder. Buying a dividend stock before the ex-dividend date seems evident since you would be entitled to receive the dividend. However, if you understand what happens when a dividend is distributed, the answer gets more involved. New dividend investors mistakenly believe that a dividend is a free money for shareholders. It's a way of getting income from holding dividend stocks. That…Read Article 16 hours agoDividends, Short-Term Pain, but Long-Term Gain? Dividend stocks drop by the dividend amount on the ex-dividend date. The stock takes a short-term hit, but the shareholders are compensated in cash on the payout date. If it's a wash, why are there so many dividend investors? Simple. Dividend investors seek income from holding their stocks long-term. They don't feel they lose anything because they are getting paid the dividend, and the short-term price drop will eventually be recovered if they hold the stock long enough. Well, that may only sometimes be the case. Benchmark Indexes Rise…Read Article 12 hours agoCan Carnival Cruise Lines Set Sail For New Highs? Carnival Cruise Lines (NYSE: CCL) has been weathering stormy seas for the last 2 years, but the skies are clearing, and smoother sailing is ahead. The headwinds are not over, but signs within the Q1 earnings report point to a return to normalcy that includes positive cash flow and debt reduction. What this means for investors is a chance to buy this stock at the lowest prices it has seen in 20 years and at an 80% discount to its prepandemic price point. The Bad Times Are Behind Carnival Cruise Lines The signal in the results…Read Article 14 hours agoBioNTech Is Ripe For A Rebound In 2023 BioNTech (NASDAQ: BNTX) got a substantial boost from the pandemic and its mRNA vaccine, developed with Pfizer (NYSE: PFE). The stock has seen a substantial correction since then due to slowing COVID sales, but the bottom is in. While COVID sales have slowed, this company is not dependent on COVID for its bread and butter and is set up for a rebound in 2023. Not only does it have a growing pipeline of drugs and candidates in the pipeline advancing toward approval, but there are factors in play that make it a potential takeover target…Read Article 10 hours agoSanofi, Regeneron Shares Pop On Big News About COPD Treatment Shares of Sanofi (NASDAQ: SNY) were up 10.20% the week ended March 24, while Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) finished with a gain of 9.68%, following promising news about the companies’ jointly developed medication Dupixent. In Phase 3 clinical trials, Dupixent reduced severe flare-ups of chronic obstructive pulmonary disease (COPD) at a far better rate than a placebo. In a joint news release, the companies said, “Dupixent is the first and only biologic to demonstrate a clinically meaningful and highly…Read Article Latest Stock Market News 7 hours agoHow major US stock indexes fared Monday 3/27/20238 hours agoSouth Dakota gov's veto of cryptocurrency regulations upheld9 hours ago3 High Yields On Breakout Watch With Analyst Tailwinds10 hours agoFed official: SVB itself was main cause of bank's failure10 hours agoSanofi, Regeneron Shares Pop On Big News About COPD Treatment11 hours agoCollapsed Silicon Valley Bank Finds a Buyer11 hours ago3 Financials The Insiders Are Buying 12 hours agoReport: Elon Musk Says Twitter Is Valued At Less Than Half of What He Paid For It Just Days After Sending Frantic Email to Employees at 2:30 A.M.12 hours agoCan Carnival Cruise Lines Set Sail For New Highs? 12 hours agoCold Stone Creamery Employees Quit En Masse After Fellow Worker Loses 3 Fingers on the Job12 hours agoDeath Tolls Rises Following Chocolate Factory Explosion13 hours agoChatGPT Just Got a Game-Changing Update — Here's What to Know Free Email Newsletter Sign up to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter: Your Email Address Sector Performance Ad Weiss RatingsBank Accounts: Frozen!In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!Find out how to protect yourself here Popular Articles1+ days ago | March 22nd | 2023 7:00AM3 Dividend Contenders to Buy Now for Long-Term Gains Later1+ days agoMullen Automotive: Investment? No. Compelling Speculation, Yes 1+ days agoWhy Wall Street Loves These 3 Penny Stocks1+ days ago3 Tech Stocks Well Positioned For Growth At A Reasonable Price 1+ days ago5 Best Dividend Capture Stocks Stock Ideas9 hours ago | March 27th | 2023 2:30PM3 High Yields On Breakout Watch With Analyst Tailwinds10 hours agoSanofi, Regeneron Shares Pop On Big News About COPD Treatment12 hours agoCan Carnival Cruise Lines Set Sail For New Highs? 14 hours agoIf Safety is Your Concern, Then Take a Look at Sandy Spring Bank14 hours agoBioNTech Is Ripe For A Rebound In 2023 Instant Alerts1 hour ago | March 27th | 2023 10:37PMBank of America Raises Amicus Therapeutics (NASDAQ:FOLD) Price Target to $17.0010 hours agoBank Pictet & Cie Asia Ltd. Boosts Stock Holdings in McDonald's Co. (NYSE:MCD)10 hours agoBank Pictet & Cie Asia Ltd. Acquires 730 Shares of PepsiCo, Inc. (NASDAQ:PEP)10 hours agoPermit Capital LLC Acquires New Position in Meta Platforms, Inc. (NASDAQ:META)10 hours agoFirst Horizon Advisors Inc. Sells 5,724 Shares of The TJX Companies, Inc. (NYSE:TJX)10 hours agoRovida Advisors Inc. Invests $11.96 Million in The Walt Disney Company (NYSE:DIS) Ad Vector VestFree Stock Analysis Report: Get Buy, Sell, or Hold RecommendationGet a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation. Analyze Any Stock Free Popular StocksCompanyCurrent PricePrice ChangeAAPLApple Inc.$158.28-1.23%MSFTMicrosoft Co.$276.38-1.49%METAMeta Platforms, Inc.$202.84-1.54%GOOGLAlphabet Inc.$102.46-2.83%AMZNAmazon.com, Inc.$98.04-0.09%TSLATesla, Inc.$191.810.74%NVDANVIDIA Co.$265.31-0.93%NIONio Inc -$8.93-1.54%BABAAlibaba Group Holding Limited$86.12-0.90%AMDAdvanced Micro Devices, Inc.$96.61-1.37%TAT&T Inc.$18.871.40%FFord Motor$11.520.09%MUMicron Technology, Inc.$59.79-2.24%Follow Stocks Analyst RatingsCompanyBrokerageActionSLGSL Green Realty Corp.CitigroupLower Price Target$35.00 ➝ $17.00JOANJOANN Inc.Bank of AmericaLower Price Target$3.50 ➝ $1.00BNTXBioNTech SEBank of AmericaLower Price Target$239.00 ➝ $194.00FOLDAmicus Therapeutics, Inc.Bank of AmericaBoost Price Target$16.00 ➝ $17.00LULULululemon Athletica Inc.BarclaysLower Price Target$394.00 ➝ $368.00PSNParsons Co.William BlairUpgradeto OutperformGMDAGamida Cell Ltd.OppenheimerLower Price Target$10.00 ➝ $8.00GERNGeron Co.The Goldman Sachs GroupInitiated Coverageat NeutralRGENRepligen Co.BenchmarkInitiated Coverageat BuyBOWLBowlero Corp.Stifel NicolausInitiated Coverageat BuyCARRCarrier Global Co.OppenheimerInitiated Coverageat OutperformLIILennox International Inc.OppenheimerInitiated Coverageat Market PerformSee All Analyst Ratings Today's Top GainersCompanyPrice ChangeIndicatorEVCIEVCI Career Colleges Holding Corp.146.15%News CoverageGap UpINNVDInnovus Pharmaceuticals Inc143.90%Gap UpEJMLLFantex, Inc.100.00%Gap UpWISAWiSA Technologies, Inc.89.47%Short Interest ↓High Trading VolumeCERPQCereplast, Inc.64.65%Gap DownHigh Trading VolumeCUENWCuentas Inc.60.00%Positive NewsGap DownHigh Trading VolumeUMLGFUnited Malt Group Limited57.20%Gap UpCCTCClean Coal Technologies, Inc.53.85%Short Interest ↓Gap UpHigh Trading VolumeFCNCAFirst Citizens BancShares, Inc.53.74%Short Interest ↓News CoveragePositive NewsGap UpHigh Trading VolumeSRAXSRAX, Inc.46.34%Gap UpLMAOULMF Acquisition Opportunities, Inc.41.59%Gap UpHigh Trading VolumeGRRRGorilla Technology Group Inc.41.15%News CoveragePositive NewsGap UpHigh Trading VolumeSee More Top Gainers Today's Top LosersCompanyPrice ChangeIndicatorESRCFESR Group Limited-84.03%News CoverageGap DownCDAKCodiak BioSciences, Inc.-56.75%Upcoming EarningsShort Interest ↑News CoverageGap DownTrading HaltedHigh Trading VolumeUBXUnity Biotechnology, Inc.-53.01%News CoverageGap DownTrading HaltedHigh Trading VolumeSPECSpectralCast, Inc.-50.65%Gap DownGMDAGamida Cell Ltd.-49.63%Analyst ReportShort Interest ↓News CoverageGap DownHigh Trading VolumeHCYTDH-CYTE, Inc.-49.50%Gap DownHigh Trading VolumeVRSRFVersarien plc-48.48%Gap DownTNLXTrans-Lux Co.-43.32%Gap DownZURAZura Bio Limited-42.76%Gap UpTrading HaltedHigh Trading VolumeJATTJATT Acquisition Corp-42.76%Gap UpHigh Trading VolumeLTONYMNC Media Investment Ltd -42.19%Gap DownHigh Trading VolumeSONNSonnet BioTherapeutics Holdings, Inc.-41.04%Short Interest ↓Positive NewsGap DownHigh Trading VolumeSee More Top Losers × Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.